Hepatic impairment No dose adjustment is needed for patients with hepatic impairment. Practical experience with using tirzepatide in clients with critical hepatic impairment is proscribed. Warning needs to be exercised when dealing with these individuals with tirzepatide (see area 5.2). Take into account that you might be able to receive https://sandrav072oko1.bcbloggers.com/profile